Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time
Breast Cancer Research and Treatment · 2025-04 · 210 (2) · 319-327
DOI: 10.1007/s10549-024-07567-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 10.12.2024. Verfasst von Elisabeth A Kappos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of Basel, Spitalstrasse 21, 4031, Basel, Switzerland. elisabet…. Hauptthemen laut MEDLINE: Breast Cancer Lymphedema, Anastomosis, Surgical, Lymph Nodes, Lymphatic Vessels. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Cancer Research Foundation, Freiwillige Akademische Gesellschaft, Rising Tide Foundation.
Abstract (Originalsprache)
Purpose
Microsurgical reconstruction, including vascularized lymph node transfer (VLNT) and lymphaticovenous anastomosis (LVA), have emerged as promising treatment options for chronic breast cancer-related lymphedema (BCRL). Despite their clinical relevance, the precise timelines for patient improvement following these interventions remain rather unexplored. Therefore, the goal of this study was to compare the long-term outcomes and improvement patterns over time of VLNT versus LVA to lay open potential differences and aid in personalized counseling of future patients.
Methods
A prospectively maintained, encrypted database was analyzed for patients with chronic BCRL treated with either VLNT or LVA with a minimum follow-up of one year. Patient-specific variables, such as body weight and circumferential arm measurements at distinct locations on both arms were documented preoperatively and on regular postoperative outpatient follow-ups.
Results
This study comprised 112 patients, of which 107 patients fully completed the one-year follow-up period. Both VLNT and LVA achieved significant arm size reductions. LVA showed an early peak in effectiveness within the first three months, followed by a subsequent decrease and eventual stabilization. Contrarily, VLNT exhibited a distinct pattern with two significant peaks at three and eighteen months.
Conclusions
VLNT and LVA are both effective in long-term lymphedema management, yet they demonstrate marked differences in the timing of improvement. VLNT shows a delayed but more durable response, in contrast to the greater but shorter-lasting surge in effectiveness achieved by LVA. Interestingly, VLNT demonstrates an earlier onset of therapeutic impact than previously understood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of Basel, Spitalstrasse 21, 4031, Basel, Switzerland. elisabeth.kappos@usb.ch.
- Faculty of Medicine, University of Basel, Basel, Switzerland. elisabeth.kappos@usb.ch.
- Breast Center, University Hospital of Basel, Basel, Switzerland. elisabeth.kappos@usb.ch.
- Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital of Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
- Faculty of Medicine, University of Zurich, Zurich, Switzerland.
- Surgical Outcome Research Center, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.
Förderung
- Swiss Cancer Research Foundation
- Freiwillige Akademische Gesellschaft
- Rising Tide Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Kappos, E. A., Fabi, A., Halbeisen, F. S., Abu-Ghazaleh, A., Stoffel, J., Aufmesser-Freyhardt, B., Bukowiecki, J., Handschin, T. M., Andree, C., Haug, M. D., Schaefer, D. J., Fertsch, S., & Seidenstücker, K. (2025). Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time. Breast Cancer Research and Treatment, 210(2), 319-327. https://doi.org/10.1007/s10549-024-07567-5
Vancouver
Kappos EA, Fabi A, Halbeisen FS, Abu-Ghazaleh A, Stoffel J, Aufmesser-Freyhardt B, et al. Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time. Breast Cancer Research and Treatment. 2025;210(2):319-327. doi:10.1007/s10549-024-07567-5
BibTeX
@article{Kappos2025,
author = {Kappos, Elisabeth A and Fabi, Adriano and Halbeisen, Florian S and Abu-Ghazaleh, Alina and Stoffel, Julia and Aufmesser-Freyhardt, Birgit and Bukowiecki, Julia and Handschin, Tristan M and Andree, Christoph and Haug, Martin D and Schaefer, Dirk J and Fertsch, Sonia and Seidenstücker, Katrin},
title = {Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time},
journal = {Breast Cancer Research and Treatment},
year = {2025},
volume = {210},
number = {2},
pages = {319--327},
doi = {10.1007/s10549-024-07567-5}
}
EUVIMED